1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival of PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Hecht, J. R.; Naing, A.; Falchook, G. S.; Patel, M. R.; Infante, J. R.; Aljumaily, R.; Wong, D. J. L.; Autio, K. A.; Wainberg, Z. A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic characterization of upper-tract urothelial carcinoma in patients with Lynch syndrome
    Journal Article

    Donahue, T. F.; Bagrodia, A.; Audenet, F.; Donoghue, M. T. A.; Cha, E. K.; Sfakianos, J. P.; Sperling, D.; Al-Ahmadie, H.; Clendenning, M.; Rosty, C.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Molecular alterations in the pathogenesis of bladder cancer subtypes and urothelial carcinoma variants
    Book Section

    Al-Ahmadie, H.; Iyer, G.
    In Hansel, D. E.; Lerner, S. P. (Eds.) Precision Molecular Pathology of Bladder Cancer (2018)

    Fulltext@MSK | Save
  • ALK fusions in renal cell carcinoma: Response to entrectinib
    Journal Article

    Tao, J. J.; Wei, G.; Patel, R.; Fagan, P.; Hao, X.; Bridge, J. A.; Arcila, M. E.; Al-Ahmadie, H.; Lee, C. H.; Li, G.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
    Meeting Abstract

    Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Targeting poor-prognosis subtypes of prostate cancer by inhibition of DNA repair gene ribonucleotide reductase small subunit M2
    Meeting Abstract

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Gerke, T. A.; Coggins, S. A. A.; Qiu, X.; Atiq, M.; Stopsack, K. H.; Lee, G. S. M.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A multifactorial model of T-cell expansion and durable clinical benefit in response to a PD-L1 inhibitor
    Meeting Abstract

    Leiserson, M. D.; Syrgkanis, V.; Gilson, A. I.; Dudik, M.; Funt, S. A.; Snyder, A.; Mackey, L.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Intratumoral CYP27A1 expression in relation to cholesterol synthesis and vitamin D signaling and its association with lethal prostate cancer
    Meeting Abstract

    Khan, N. A.; Stopsack, K. H.; Allott, E. H.; Gerke, T. A.; Giovannucci, E. L.; Mucci, L. A.; Kantoff, P. W.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Phase I study of AZD6738, an inhibitor of ataxia telangiectasia Rad3-related (ATR), in combination with olaparib or durvalumab in patients (pts) with advanced solid cancers
    Meeting Abstract

    Krebs, M. G.; Lopez, J.; El-Khoueiry, A.; Bang, Y. J.; Postel-Vinay, S.; Abida, W.; Carter, L.; Xu, W.; Im, S. A.; Pierce, A.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • IMAAGEN study biomarker analysis in patients with long term response to abiraterone acetate with prednisone for non-metastatic castrate resistant prostate cancer
    Meeting Abstract

    Chornoguz, O.; Shen, D.; Kapoor, G.; Li, W.; Phillips, J.; Ryan, C. J.; Crawford, E. D.; Shore, N. D.; Underwood, W.; Taplin, M. E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save